Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2022 Jul 29

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Letter to the Editor   Free accessfree

Minerva Medica 2022 Jul 29

DOI: 10.23736/S0026-4806.22.08297-0

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Third-line therapy for HER2-positive advanced breast cancer: a case report

Ying SONG, Wenzhou SUN

Department of Breast Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China


PDF


top of page